NFL Biosciences is a French company, its stock is traded on Euronext Growth Paris, not the NSE (National Stock Exchange of India). Factors affecting NFL.NSE would be nonsensical, so assuming the user meant NFL Biosciences, Eurgonext Growth Paris: Clinical Trial Results: Positive trial data for NFL-101, its smoking cessation drug, can significantly increase stock price. Negative or inconclusive results can cause it to fall. Regulatory Approvals: Approval of NFL-101 by regulatory bodies like the FDA or EMA would be a major catalyst, driving the stock price up. Delays or rejections would negatively impact it. Market Sentiment: Overall investor confidence in the pharmaceutical sector and smaller biotech companies influences the price. Positive sentiment leads to increased investment, vice-versa. Competition: The presence of competing smoking cessation products and the effectiveness of those products impact NFL Biosciences' market share and potential revenue, affecting the stock price. Financial Performance: The company's cash position, ability to raise capital, and burn rate are crucial. Strong financials provide stability, while concerns about funding affect stock price. Partnerships & Licensing: Securing partnerships with larger pharmaceutical companies for development or commercialization of NFL-101 would positively impact the stock. News & Announcements: Significant news releases, like new study initiations, presentations at conferences, or management changes, can all create price volatility.